Search research articles
Contact Us
Filters
Showing results (541-550 of 976) with videos related to
Page
of 98
Sort By:
Circulation
|
January 13, 1999
Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms
E L Henderson, Y J Geng, G K Sukhova, et al.
Annals of Clinical Biochemistry
|
March 1, 1983
Genetic bisalbuminaemia occurring together with myeloma
F A Porta, P G Riches, D Richardson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 11, 2016
Pretreatment quality-of-life score is a better discriminator of oesophageal cancer survival than performance status
Biniam Kidane, Joanne Sulman, Wei Xu, et al.
Cancer Research
|
January 1, 1991
Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody
M J Tilby, C Johnson, R J Knox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience
J J Knox, D Hedley, A Oza, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 12, 2013
Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer
Junqiang Tian, Hiroshi Doi, Matthias Saar, et al.
Analytical Chemistry
|
June 8, 2011
Automated particle electrophoresis: modeling and control of adverse chamber surface properties
R J Knox, N L Burns, J M Van Alstine, et al.
Biochemical Pharmacology
|
December 15, 1992
The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--I. Purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)
G M Anlezark, R G Melton, R F Sherwood, et al.
Cancer Research
|
August 17, 2000
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy
R J Knox, T C Jenkins, S M Hobbs, et al.
Biotechnology & Genetic Engineering Reviews
|
January 1, 1994
The structures and catalytic mechanisms of active-site serine beta-lactamases
J Lamotte-Brasseur, J Knox, J A Kelly, et al.
Page
of 98
Search research articles
Search
Showing results (541-550 of 976) with videos related to
Sort By:
Page
of 98
Circulation
|
January 13, 1999
Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms
E L Henderson, Y J Geng, G K Sukhova, et al.
Annals of Clinical Biochemistry
|
March 1, 1983
Genetic bisalbuminaemia occurring together with myeloma
F A Porta, P G Riches, D Richardson, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
August 11, 2016
Pretreatment quality-of-life score is a better discriminator of oesophageal cancer survival than performance status
Biniam Kidane, Joanne Sulman, Wei Xu, et al.
Cancer Research
|
January 1, 1991
Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody
M J Tilby, C Johnson, R J Knox, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 28, 2004
Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience
J J Knox, D Hedley, A Oza, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 12, 2013
Radioprotection and cell cycle arrest of intestinal epithelial cells by darinaparsin, a tumor radiosensitizer
Junqiang Tian, Hiroshi Doi, Matthias Saar, et al.
Analytical Chemistry
|
June 8, 2011
Automated particle electrophoresis: modeling and control of adverse chamber surface properties
R J Knox, N L Burns, J M Van Alstine, et al.
Biochemical Pharmacology
|
December 15, 1992
The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)--I. Purification and properties of a nitroreductase enzyme from Escherichia coli--a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)
G M Anlezark, R G Melton, R F Sherwood, et al.
Cancer Research
|
August 17, 2000
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy
R J Knox, T C Jenkins, S M Hobbs, et al.
Biotechnology & Genetic Engineering Reviews
|
January 1, 1994
The structures and catalytic mechanisms of active-site serine beta-lactamases
J Lamotte-Brasseur, J Knox, J A Kelly, et al.
Page
of 98